DE69940359D1 - Neues protein tab2 - Google Patents

Neues protein tab2

Info

Publication number
DE69940359D1
DE69940359D1 DE69940359T DE69940359T DE69940359D1 DE 69940359 D1 DE69940359 D1 DE 69940359D1 DE 69940359 T DE69940359 T DE 69940359T DE 69940359 T DE69940359 T DE 69940359T DE 69940359 D1 DE69940359 D1 DE 69940359D1
Authority
DE
Germany
Prior art keywords
tab2
signal transduction
new protein
tak1
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940359T
Other languages
English (en)
Inventor
Kunihiro Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69940359D1 publication Critical patent/DE69940359D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69940359T 1999-11-19 1999-11-19 Neues protein tab2 Expired - Lifetime DE69940359D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/006466 WO2001038527A1 (fr) 1999-11-19 1999-11-19 Nouvelle proteine tab2

Publications (1)

Publication Number Publication Date
DE69940359D1 true DE69940359D1 (de) 2009-03-12

Family

ID=14237333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940359T Expired - Lifetime DE69940359D1 (de) 1999-11-19 1999-11-19 Neues protein tab2

Country Status (6)

Country Link
US (3) US7153664B2 (de)
EP (1) EP1234880B9 (de)
JP (1) JP4488665B2 (de)
AT (1) ATE421571T1 (de)
DE (1) DE69940359D1 (de)
WO (1) WO2001038527A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4488665B2 (ja) 1999-11-19 2010-06-23 邦弘 松本 新規ｔａｂ２蛋白質
JPWO2004022599A1 (ja) * 2002-08-22 2005-12-22 株式会社ペプタイドドア 融合抗体及びその作成方法
GB0306071D0 (en) * 2003-03-17 2003-04-23 Novartis Ag Organic compounds
US20070197457A1 (en) * 2003-04-01 2007-08-23 Dan Gazit Tak1-mediated inhibition of osteogenesis
US8765370B2 (en) * 2009-06-11 2014-07-01 Scinopharm Taiwan, Ltd Inhibition-based high-throughput screen strategy for cell clones
KR101595318B1 (ko) 2014-03-25 2016-02-18 한국알프스 주식회사 다채널 led 조명기구에서 채널간의 전류편차 최소화 제어방법
WO2016011155A1 (en) * 2014-07-15 2016-01-21 Kapre Subhash V Genetically detoxified pertussis that maintains intrinsic adjuvant activity
CN110201418B (zh) * 2019-05-09 2020-10-27 西安交通大学 一种基于固定化SNAP-tag融合蛋白的细胞膜色谱柱及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5576423A (en) * 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
JP3907247B2 (ja) * 1996-04-24 2007-04-18 中外製薬株式会社 Ｔａｂ１蛋白質及びそれをコードするｄｎａ
ES2230586T3 (es) * 1996-04-24 2005-05-01 Chugai Seiyaku Kabushiki Kaisha Proteina tab1 y asdn que la codifica.
JP4488665B2 (ja) 1999-11-19 2010-06-23 邦弘 松本 新規ｔａｂ２蛋白質

Also Published As

Publication number Publication date
US20120064084A1 (en) 2012-03-15
EP1234880A1 (de) 2002-08-28
US8491900B2 (en) 2013-07-23
US7153664B2 (en) 2006-12-26
EP1234880B9 (de) 2009-09-23
WO2001038527A1 (fr) 2001-05-31
US20070161565A1 (en) 2007-07-12
JP4488665B2 (ja) 2010-06-23
US20030040050A1 (en) 2003-02-27
US8058241B2 (en) 2011-11-15
EP1234880A4 (de) 2004-03-31
EP1234880B1 (de) 2009-01-21
ATE421571T1 (de) 2009-02-15

Similar Documents

Publication Publication Date Title
DE69940359D1 (de) Neues protein tab2
DE69917469D1 (de) Pyrimidin derivate
CA2354023A1 (en) Phenylglycine derivatives
CA2230082A1 (en) Amide compounds and use thereof
DK1193270T3 (da) Pyrrolobenzodiazepiner
DK482088D0 (da) Anvendelse af 1,3,7-trisubstituerede purin-2,6-dion-forbindelser til fremstilling af et laegemiddel med interleukin-1-inhiberende virkning
PT1069106E (pt) Compostos de dimetil-(3-aril-but-3-enil)amina de formula i com efeito analgesico
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
NO980522L (no) En-sats syntese av 2-oksazolidinonderivater
DE59509982D1 (de) Befestigungselement zum Eintreiben in harte Aufnahmematerialien mittels pulverkraftbetriebener Setzgeräte
BR0309748A (pt) Derivados de n-acil piperidina e composição compreendendo os mesmos
HRP20090180T1 (en) Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof
FR2796732B1 (fr) Piece d'horlogerie a affichage du quantieme
EP1632484A4 (de) Thiadiazolinderivat
LV10448A (lv) Piperazinilkamparsulfoniloksitocina antagonista aizvietotie amidu atvasinajumi
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
TR199501070A2 (tr) Dihidro-2,3-benzodiazepin türevinin kristalli bicimi.
HUP0302212A2 (hu) Amidvegyület-alapú fungicid hatóanyag-keverék és alkalmazása
NO951533D0 (no) Piezoelektrisk element med regulerbar polarisasjon
HUP0400745A2 (hu) Piridoindolonszármazékokon és rákellenes szereken alapuló gyógyszeripari kombinációk és alkalmazásuk
ATE58129T1 (de) Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung.
DE29712635U1 (de) Verstellbarer Saitenhalter zur Klangverbesserung von Streichinstrumenten
JP2002339481A5 (de)
KR820001794Y1 (ko) 욕실용 세면도구 걸이

Legal Events

Date Code Title Description
8364 No opposition during term of opposition